The (re)discovery of tumor-intrinsic determinants of immune sensitivity by functional genetic screens

David W. Vredevoogd(The Netherlands Cancer Institute), Daniel S. Peeper(The Netherlands Cancer Institute)
Immuno-Oncology Technology
October 1, 2021
10.1016/j.iotech.2021.100043
Cited by 9

Related Papers

BRAFE600-associated senescence-like cell cycle arrest of human naevi
|Nature|2005|2.1k
The essence of senescence: Figure 1.
|Genes & Development|2010|2k
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
|Nature Communications|2014|633
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
|Nature|2017|161
Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
|EMBO Molecular Medicine|2015|143